September 15, 2014, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013. The 52nd Annual R&D Awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
“A key component of our strategy is to offer the highest quality and most innovative products. Recognition for two R&D Magazine awards exemplifies our technical expertise and leadership in providing differentiated solutions to a broad range of customers across the life science industry,” said Udit Batra, President and Chief Executive Officer of Merck Millipore. “In 2013, Merck Millipore invested €160 million in R&D activities, and we will continue to support efforts to drive future advancements in our portfolio of offerings. We are most appreciative of those employees who have dedicated their careers to furthering scientific advancement in these fields.”
The Merck Millipore products that were recognized are:
With nearly 800 employees focused on R&D, Merck Millipore is working with customers to develop innovative solutions for the research, development and production of biopharmaceuticals and biotech processes worldwide.
Widely regarded as the “Oscars of Invention”, the R&D 100 Awards identify and celebrate the top technology products of the year. Past winners have included sophisticated testing equipment, innovative new materials, chemistry breakthroughs, biomedical products, consumer items, and high-energy physics. The R&D 100 Awards spans industry, academia, and government-sponsored research.
The winners of the R&D 100 Awards are selected by an independent judging panel and the editors of R&D Magazine.
About Merck Millipore
Merck Millipore is the Life Science division of Merck and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2013 revenues of €2.6 billion Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of € 11.1 billion in 2013. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.
About R&D Magazine
Since its founding in 1959 as Industrial Research, R&D Magazine has served research scientists, engineers and technical staff at laboratories around the world, providing timely, informative news and useful technical articles that broaden readers’ knowledge of the research and development industry and improve the quality of their work. R&D Magazine is a publication of Advantage Business Media (www.advantagebusinessmedia.com).